Clinical Trial Update: Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function [Phase 1]

View source ↗

Summary

This is a Phase 1 pharmacokinetic study evaluating HS-10365 capsule in subjects with hepatic impairment and normal hepatic function, in the context of advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• HS-10365 capsule

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: NSCLC (advanced Non-small Cell Lung Cancer) | Phase 1 | Status: NOT_YET_RECRUITING